L Hafström

758 total citations
46 papers, 604 citations indexed

About

L Hafström is a scholar working on Oncology, Epidemiology and Hepatology. According to data from OpenAlex, L Hafström has authored 46 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Epidemiology and 11 papers in Hepatology. Recurrent topics in L Hafström's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and Pancreatic and Hepatic Oncology Research (6 papers). L Hafström is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and Pancreatic and Hepatic Oncology Research (6 papers). L Hafström collaborates with scholars based in Sweden and United States. L Hafström's co-authors include Stig Bengmark, O Almersjö, Peter Naredi, Stephen B. Howell, Lars Nilsson, Paul A. Andrews, R D Christen, Doreen K. Hom, Kaj Sundqvist and Carol L. MacLeod and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Surgery and European Journal of Cancer.

In The Last Decade

L Hafström

46 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Hafström Sweden 14 241 239 208 112 108 46 604
Kiyohiko Dohi Japan 14 168 0.7× 132 0.6× 195 0.9× 71 0.6× 257 2.4× 43 751
W Y Lui Taiwan 16 252 1.0× 288 1.2× 303 1.5× 217 1.9× 192 1.8× 29 900
Toshiro Ogata Japan 16 216 0.9× 99 0.4× 216 1.0× 124 1.1× 158 1.5× 61 579
A Gavelli Monaco 10 152 0.6× 474 2.0× 547 2.6× 154 1.4× 88 0.8× 34 823
H. Raith Germany 11 207 0.9× 123 0.5× 155 0.7× 186 1.7× 137 1.3× 16 732
Robert Malafosse France 12 302 1.3× 454 1.9× 463 2.2× 144 1.3× 81 0.8× 28 809
Lister Hill United States 6 556 2.3× 158 0.7× 176 0.8× 34 0.3× 144 1.3× 6 824
Keisuke Inaba Japan 15 230 1.0× 211 0.9× 387 1.9× 139 1.2× 259 2.4× 56 789
J.-L. Canon Belgium 11 486 2.0× 177 0.7× 106 0.5× 39 0.3× 197 1.8× 22 685
Beata Herberger Austria 13 516 2.1× 398 1.7× 337 1.6× 91 0.8× 224 2.1× 19 810

Countries citing papers authored by L Hafström

Since Specialization
Citations

This map shows the geographic impact of L Hafström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Hafström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Hafström more than expected).

Fields of papers citing papers by L Hafström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Hafström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Hafström. The network helps show where L Hafström may publish in the future.

Co-authorship network of co-authors of L Hafström

This figure shows the co-authorship network connecting the top 25 collaborators of L Hafström. A scholar is included among the top collaborators of L Hafström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Hafström. L Hafström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nyström, Hanna, Peter Naredi, L Hafström, & Malin Sund. (2011). Type IV collagen as a tumour marker for colorectal liver metastases. European Journal of Surgical Oncology. 37(7). 611–617. 35 indexed citations
2.
3.
Öman, Mikael, Stefan Lundqvist, Bengt Gustavsson, L Hafström, & Peter Naredi. (2005). Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous Vasopressin in non-resectable pancreas cancer. Cancer Chemotherapy and Pharmacology. 56(6). 603–609. 9 indexed citations
4.
Lindnér, Per, J Tölli, Peter Naredi, Mikael Öman, & L Hafström. (2004). Blood flow in liver tumors--effects of vasoactive drugs estimated with xenon (133Xe) clearance.. PubMed. 51(57). 781–6. 2 indexed citations
5.
Naredi, Peter, et al.. (2003). A comparison between hepatic artery ligation and portal 5-Fu infusion versus 5-Fu intra arterial infusion for colorectal liver metastases. European Journal of Surgical Oncology. 29(5). 459–466. 8 indexed citations
6.
Engarås, Boel, J Kewenter, Ola Nilsson, Hans Wedel, & L Hafström. (2001). CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease. European Journal of Surgical Oncology. 27(1). 43–48. 8 indexed citations
7.
Öman, Mikael, et al.. (2001). Treatment of non-resectable pancreatic cancer with intraperitoneal 5-FU and leucovorin IV. European Journal of Surgical Oncology. 27(5). 477–481. 5 indexed citations
8.
Permert, Johan, L Hafström, Peter Nygren, & Ingrid Glimelius. (2001). A Systematic Overview of Chemotherapy Effects in Pancreatic Cancer. Acta Oncologica. 40(2). 361–370. 31 indexed citations
9.
Westman, Gunnar, Bengt Bergman, M. Albertsson, et al.. (1999). Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial. European Journal of Cancer. 35(4). 586–595. 43 indexed citations
10.
Lindnér, Per, Dennis D. Heath, David R. Shalinsky, et al.. (1993). Regional lymphatic drug exposure following intraperitoneal administration of 5-fluorouracil, carboplatin, and etoposide. Surgical Oncology. 2(2). 105–112. 12 indexed citations
11.
Athlin, L., Holmberg Sb, & L Hafström. (1991). Macrophage function and surgery. A clinical review with special reference to phagocytosis.. PubMed. 157(3). 163–70. 15 indexed citations
12.
Forssell‐Aronsson, Eva, Lars Jacobsson, S. Mattsson, et al.. (1991). Comparison of Seven Iodine-Labelled Monoclonal Antibodies in Nude Mice with Human Colon Carcinoma Xenografts. Acta Oncologica. 30(3). 385–393. 2 indexed citations
13.
Holmberg, Stig B., L Hafström, Eva Forssell‐Aronsson, et al.. (1989). Kinetics of Radioiodinated Monoclonal antibodies in the Rat: Influence of Tumour Growth and Reticuloendothelial System Host Modulation. Acta Oncologica. 28(5). 699–703. 2 indexed citations
14.
Hafström, L. (1988). Liver cancer--present status.. PubMed. 541. 57–62. 1 indexed citations
15.
Hafström, L & Göran Carlsson. (1986). Arterial devascularisation procedures in the treatment of liver cancer.. PubMed. 200. 85–90. 2 indexed citations
16.
Hafström, L, et al.. (1982). Experimental set-up for studies of microwave-induced hyperthermia in rats. Physics in Medicine and Biology. 27(3). 397–406. 7 indexed citations
17.
Hafström, L, et al.. (1980). Intraarterial 5-FU infusion with or without oral testolactone treatement in irresectable pancreatic cancer.. PubMed. 146(6). 445–8. 8 indexed citations
18.
Almersjö, O, et al.. (1976). Results of liver dearterialization combined with regional infusion of 5-fluorouracil for liver cancer.. PubMed. 142(2). 131–8. 27 indexed citations
19.
Almersjö, O & L Hafström. (1974). The "suction knife". A new device for dividing liver parenchyma.. PubMed. 140(7). 581–3. 5 indexed citations
20.
Almersjö, O, et al.. (1968). Changes in coagulation factors after hepatic dearterialization in man. The American Journal of Surgery. 116(3). 414–418. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiyohiko Dohi Breakdown of academic impact, for papers by W Y Lui Breakdown of academic impact, for papers by Toshiro Ogata Breakdown of academic impact, for papers by A Gavelli Breakdown of academic impact, for papers by H. Raith Breakdown of academic impact, for papers by Robert Malafosse Breakdown of academic impact, for papers by Lister Hill Breakdown of academic impact, for papers by Keisuke Inaba Breakdown of academic impact, for papers by J.-L. Canon Breakdown of academic impact, for papers by Beata Herberger
Rankless by CCL
2026